The median time‐to‐recurrence in the group with AFP level ≥5.4 ng/mL (dotted line; n = 327) was 29.0 months, and the 1‐, 2‐, and 3‐year cumulative HCC recurrence rates were 30.0%, 48.1%, and 53.2%, respectively. This evidence concerns the gene AFP and hepatocellular carcinoma.